Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Synalar 0.025% gel
1304000N0BBAIBD
|
Synalar | Fluocinolone acetonide | Skin | 7,926 |
|
Synalar 0.025% ointment
1304000N0BBAGBB
|
Synalar | Fluocinolone acetonide | Skin | 2,578 |
|
Synalar 0.025% cream
1304000N0BBAAAB
|
Synalar | Fluocinolone acetonide | Skin | 1,872 |
|
Synalar 1 in 4 Dilution 0.00625% ointment
1304000N0BBAHBC
|
Synalar | Fluocinolone acetonide | Skin | 1,675 |
|
Synalar 1 in 4 Dilution 0.00625% cream
1304000N0BBADAD
|
Synalar | Fluocinolone acetonide | Skin | 641 |
|
Synalar C ointment
1304000N0BBAMCC
|
Synalar | Fluocinolone acetonide | Skin | 442 |
|
Synalar C cream
1304000N0BBAKCA
|
Synalar | Fluocinolone acetonide | Skin | 403 |
|
Synalar N ointment
1304000N0BBANCD
|
Synalar | Fluocinolone acetonide | Skin | 10 |
|
Synalar 1 in 10 Dilution 0.0025% cream
1304000N0BBAEAE
|
Synalar | Fluocinolone acetonide | Skin | 3 |
|
Synalar N cream
1304000N0BBALCB
|
Synalar | Fluocinolone acetonide | Skin | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.